Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year. The diabetes-focused healthcare company ...

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going ...

CGMs have saved my life after a heart attack four years ago. I recently tried the Dexcom Stelo OTC CGM, and it's been mighty ...

Dexcom and Fidelity Management & Research Company contributed to the financing. This investment comes as part of a new health ...

Dexcom revealed on Tuesday an artificial intelligence function for their Stelo continuous glucose monitor that allows users ...

Dexcom (Nasdaq:DXCM) announced today that it launched a proprietary generative AI platform integrated with its glucose ...

Dexcom is bringing generative AI to Stelo users, starting with weekly personalized reports about their glucose ...

In the meantime, we look at two S&P 500 stocks—DexCom and Albemarle—that are already on sale for investors to buy in 2025.

Dexcom this week began rolling out the feature, which analyzes data to provide personalized tips and recommendations.

Dexcom has launched a generative AI platform aimed at providing personalized lifestyle tips to the users of its ...

DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...